Chanil 34 mg/ml oral suspension for cattle
Chanil 34 mg/ml oral suspension for cattle
Authorised
- Oxyclozanide
Product identification
Medicine name:
Chanil 34 mg/ml oral suspension for cattle
Rumenil 34 mg/ml suspensie voor oraal gebruik voor runderen
Active substance:
- Oxyclozanide
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxyclozanide34.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal13day
-
Milk108hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AG06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- 10 L: High Density Polyethylene (HDPE) container with a HDPE cap and an aluminium foil seal. The product can be marketed with or without an outer carton.
- 5L:White High Density Polyethylene HDPE flexi containers with a Polypropylene cap and a PVDC seal The product can be marketed with or without an outer carton.
- 2.5L:White High Density Polyethylene HDPE flexi containers with a Polypropylene cap and a PVDC seal The product can be marketed with or without an outer carton.
- 1L:White High Density Polyethylene HDPE flexi containers with a Polypropylene cap and a PVDC seal. The product can be marketed with or without an outer carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 119047
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0368/001
Concerned member states:
-
Austria
-
Belgium
-
France
-
Netherlands
-
Romania
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 26/01/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?: